Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enzyme (MLN) vs Sui (SUI) Price & Performance

Price performance (Past 24H)

Key statistics

Enzyme vs Sui — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Sui trades at Rp12,104 (market cap Rp49,5T, Rp2,02T 24h volume). The key difference: Sui is far larger — about 369045× Enzyme's market cap, and Sui's supply is capped (4,1B / 10B SUI (41%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Sui for 37 Days on average.

MLNSUI
Market Cap
Rp134,13MRp49,5T
Volume (24h)
Rp104,56MRp2,02T
Circulating Supply
3,3M MLN4,1B / 10B SUI (41%)
Typical Hold Time
29 Days37 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Sui

Sui is currently trading at Rp12,306 with a market cap of Rp50.06T, showing a bearish technical signal overall. The asset has 41% circulating supply with a 37-day average hold time. Technical indicators show mixed signals with moving averages bearish but oscillators neutral. Recent ecosystem developments include strategic partnerships expanding token utility and lending activities on the Sui blockchain.

Overall outlook remains cautious with bearish technical pressure but neutral momentum. Key opportunities include growing ecosystem partnerships and expanding DeFi integration. Major risks include high volatility, regulatory uncertainty, and the asset trading near pivot point resistance levels.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MLN

No sentiment data available yet.

SUI
42% Buy58% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN

About Sui

Sui is a first-of-its-kind Layer-1 blockchain and smart contract platform designed from the bottom up to make digital asset ownership fast, private, secure, and accessible to everyone. Based on the Move programming language, its object-centric model enables parallel execution, sub-second finality, and rich on-chain assets. Sui supports a wide range of applications with unrivaled speed at a low cost.

Read more on SUI